ImPACT Executive Talks Concussions with CLR
Dr. Jim Gyurke is not your average Chief Sales and Marketing Officer.
Gyurke received his bachelor’s degree in psychology from St. Vincent College and his PhD in developmental psychology from Loyola University in Chicago. He completed a clinical internship at Northwestern University’s Prentice Women’s Hospital, Department of Pediatrics. His primary research interests have included the development of high-risk infants, assessment of intelligence and general cognitive abilities, and psychometric investigations of various standardized assessment tools used for predicting academic success. He has authored numerous articles and chapters and has served as an ad hoc consultant for the Centers for Disease Control and Prevention, National Institute of Mental Health, and the National Institute of Child Health and Human Development.
With that academic pedigree combined with his new role at ImPACT, one of the world’s leading technology and testing companies in the concussion industry, we wanted share his perspective with our readers.
Question: The evolution of the ImPACT test. How will it continue to evolve?
Answer: “ImPACT is committed to remaining the gold standard computerized neurocognitive assessment for mild TBI (concussion). Thus, we continue to collect data on ImPACT on various specific clinical subgroups and explore ImPACT’s applications among a variety of clinical populations. Further, we continue to collaborate on research with the leading clinicians and researchers across a number of countries and settings to further establish the clinical utility of ImPACT.”
(To see the rest of this interview, visit: https://concussionpolicyandthelaw.com/concussion-litigation-reporter/)